Search Results - "KLOECKER, GOETZ H"

Refine Results
  1. 1

    Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer by Rabinowits, Guilherme, Gerçel-Taylor, Cicek, Day, Jamie M, Taylor, Douglas D, Kloecker, Goetz H

    Published in Clinical lung cancer (2009)
    “…Abstract Purpose To date, there is no screening test for lung cancer shown to affect overall mortality. MicroRNAs (miRNAs) are a class of small noncoding RNA…”
    Get full text
    Journal Article
  2. 2

    Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature by Haninger, Diana M, Kloecker, Goetz H, Bousamra II, Michael, Nowacki, Michael R, Slone, Stephen P

    Published in Modern pathology (01-04-2014)
    “…The current diagnostic criteria for hepatoid adenocarcinoma of lung include typical acinar or papillary adenocarcinoma and a component resembling…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Argatroban for anticoagulation during cardiac surgery by Martin, Monte E., Kloecker, Goetz H., Laber, Damian A.

    Published in European journal of haematology (01-02-2007)
    “…Background: The aim of this study was to report our experience and review the published data on argatroban administration during adult cardiac surgery…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Expression and clinical significance of CXCR5/CXCL13 in human non-small cell lung carcinoma by SINGH, RAJESH, GUPTA, PRANAV, KLOECKER, GOETZ H, SINGH, SHAILESH, LILLARD, JAMES W

    Published in International journal of oncology (01-12-2014)
    “…CXCR5 and/or CXCL13 expression is elevated in certain carcinomas and lymphomas. To determine if these factors are involved in progression of non-small cell…”
    Get full text
    Journal Article
  7. 7

    Detection of Immunoglobulin G against E7 of Human Papillomavirus in Non-Small-Cell Lung Cancer by Kwon, Amy, Storey, Raul, Kloecker, Goetz H., Ghim, Shin-je, Jenson, A. Bennett, Joh, Joongho

    Published in Journal of Oncology (01-01-2013)
    “…Background. A significant number of non-small-cell lung cancers (NSCLC) have human papillomavirus (HPV) DNA integrated in their genome. This study sought to…”
    Get full text
    Journal Article
  8. 8

    Radon and lung cancer by Sethi, Tarsheen K, El-Ghamry, Moataz N, Kloecker, Goetz H

    Published in Clinical advances in hematology & oncology (01-03-2012)
    “…Lung cancer is the leading cause of cancer-related deaths worldwide. Radon exposure is the second leading cause of lung cancer, following tobacco smoke. Radon…”
    Get full text
    Journal Article
  9. 9

    Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial by Han, Baohui, Feinstein, Trevor, Shi, Yuankai, Chen, Gongyan, Yao, Yu, Hu, Chunhong, Shi, Jianhua, Feng, Jifeng, Wu, Huijuan, Cheng, Ying, Guo, Qi-sen, Jie, Zhijun, Ye, Feng, Zhang, Yiping, Liu, Zhihua, Mao, Weidong, Zhang, Liangming, Lu, Junguo, Zhao, Jun, Bazhenova, Lyudmila, Ruiz, Jimmy, Kloecker, Goetz H, Sujith, Kalmadi R, Oliff, Ira A, Wong, Matthew, Liu, Bin, Wu, Yanping, Huang, Lan, Sun, Yan, Han, Baohui, Feinstein, Trevor, Shi, Yuankai, Cheng, Gongyan, Yao, Yu, Hu, Chunhong, Shi, Jianhua, Feng, Jifeng, Wu, Huijuan, Cheng, Ying, Guo, Qi-sen, Jie, Zhijun, Ye, Feng, Zhang, Yiping, Liu, Zhihua, Mao, Weidong, Zhang, Liangming, Lu, Junguo, Zhao, Jun, Bazhenova, Lyudmila, Ruiz, Jimmy, Kloecker, Goetz, Kalmadi, R Sujith, Oliff, Ira, Wong, Matthew, Liu, Bin, Wu, Yanping, Huang, Lan, Sun, Yan, Luo, Feng, Zhou, Jian-ying, Pan, Hongming, Wang, Huaqing, Liu, Chunling, Cao, Lejie, Huang, Chao Hui, Thara, Eddie, Li, Xiaoling, Jiang, Da, Mowat, Rex B, Hrom, John S, Nagrial, Adnan, Jain, Vikram, Karim, Nagla A, Shunyakov, Leonid V, Kiberu, Andrew, Jennens, Ross, Lloyd, Ken, Wang, Zhongkun, Du, Lihua, Li, Helen

    Published in The lancet respiratory medicine (01-10-2024)
    “…There is an unmet need for second-line and third-line treatments that are effective and tolerable for advanced or metastatic non-small-cell lung cancer (NSCLC)…”
    Get full text
    Journal Article
  10. 10

    A Phase I study of thalidomide, Capecitabine and temozolomide in advanced cancer by Laber, Damian A., Khan, M. Iltaf, Kloecker, Goetz H., Schonard, Cassandra, Taft, Beverly S., Salvador, Carolina

    Published in Cancer biology & therapy (01-06-2007)
    “…Aim: To develop a novel oral antiangiogenic and immunomodulatory chemotherapy regimen against advanced cancers. Methods: Patients were enrolled in cohorts of 3…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Phase II trial of second-line erlotinib and digoxin for nonsmall cell lung cancer (NSCLC) by Kloecker, Goetz, Kayali, Janjua, Laber, Miller

    Published in Open access journal of clinical trials (01-01-2011)
    “…Background: In vitro digoxin sensitizes cancer cells to the induction of apoptosis by chemotherapy. Inhibition of the Na/K-ATPase enzyme by ouabain disturbs…”
    Get full text
    Journal Article
  13. 13

    Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond by Kanaan, Zeyad, Kloecker, Goetz H, Paintal, Ajit, Perez, Cesar A

    Published in OncoTargets and therapy (01-01-2015)
    “…Lung cancer is the leading cause of cancer-related mortality in both sexes, accounting for over one quarter of cancer deaths. Non-small-cell lung cancer…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Treatment and outcomes of non-small-cell lung cancer patients with high comorbidity by Rios, Jorge, Gosain, Rahul, Goulart, Bernardo Hl, Huang, Bin, Oechsli, Margaret N, McDowell, Jaclyn K, Chen, Quan, Tucker, Thomas, Kloecker, Goetz H

    Published in Cancer management and research (01-01-2018)
    “…The life expectancy of untreated non-small-cell lung cancer (NSCLC) is dismal, while treatment for NSCLC improves survival. The presence of comorbidities is…”
    Get full text
    Journal Article
  16. 16

    CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis by Gupta, Pranav, Sharma, Praveen K, Mir, Hina, Singh, Rajesh, Singh, Nalinaksha, Kloecker, Goetz H, Lillard, Jr, James W, Singh, Shailesh

    Published in Oncotarget (30-10-2014)
    “…Poor clinical outcome of lung cancer (LuCa) is primarily due to lack of knowledge about specific molecules involved in its progression and metastasis. In this…”
    Get full text
    Journal Article
  17. 17

    CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases by Mir, Hina, Singh, Rajesh, Kloecker, Goetz H, Lillard, Jr, James W, Singh, Shailesh

    Published in Oncotarget (30-04-2015)
    “…Lung cancer (LuCa) is the leading cause of cancer-related deaths worldwide regardless of the gender. High mortality associated with LuCa is due to metastasis,…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer by Joh, Joongho, Jenson, A. Bennett, Moore, Grace D., Rezazedeh, Arash, Slone, Stephen P., Ghim, Shin-je, Kloecker, Goetz H.

    Published in Experimental and molecular pathology (01-12-2010)
    “…Certain types of human papillomavirus (HPV) induce cancers, especially cervical cancers in women. A meta-analysis of the literature suggests that HPV is also…”
    Get full text
    Journal Article